Alniche Lifesciences, a leading and fast-growing pharmaceutical company in India, has announced plans to extend its reach and impact in the respiratory care sector with a new portfolio of products. These innovative solutions are designed to effectively address a wide range of respiratory conditions, aligning with the increasing prevalence of respiratory issues in India due to factors such as air pollution and urbanization.
Mr. Girish Arora, Founder & MD – Alniche Lifesciences, emphasized the company’s commitment to enhancing patient outcomes and healthcare delivery. He stated, “As we expand our footprint in the respiratory segment, we look forward to working with healthcare providers, patient advocacy groups, and other stakeholders to improve patient outcomes and advance healthcare throughout India.” This expansion showcases Alniche’s dedication to respiratory health and its mission to deliver high-quality, innovative healthcare solutions.
